Cargando…
Salivary alpha‐synuclein as a potential fluid biomarker in Parkinson’s disease: A systematic review and meta‐analysis
INTRODUCTION: Lewy bodies are the pathological hallmarks of Parkinson's disease. There is a need for effective biomarker that is cost effective, less invasive, and easily reproducible with good sensitivity and specificity and can be used to diagnose the condition early and track its severity an...
Autores principales: | Kharel, Sanjeev, Ojha, Rajeev, Bist, Anil, Joshi, Surya Prakash, Rauniyar, Robin, Yadav, Jayant Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917264/ https://www.ncbi.nlm.nih.gov/pubmed/35309157 http://dx.doi.org/10.1002/agm2.12192 |
Ejemplares similares
-
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease
por: Angius, Fabrizio, et al.
Publicado: (2023) -
Future of Monoclonal Antibody Therapy in Parkinson’s Disease
por: Kharel, Sanjeev, et al.
Publicado: (2022) -
Prevalence of Stroke in Asian Patients with Sickle Cell Anemia: A Systematic Review and Meta-Analysis
por: Kuikel, Sandip, et al.
Publicado: (2021) -
Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson’s Disease
por: Vivacqua, Giorgio, et al.
Publicado: (2016) -
Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)